Paul Sauer - 22 Aug 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP Process Dev, Manufacturing
Signature
Paul Sauer, by /s/ Ron Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
22 Aug 2022
Net transactions value
-$77,785
Form type
4
Filing time
24 Aug 2022, 16:47:25 UTC
Previous filing
29 Jul 2022
Next filing
07 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale $77,785 -3,000 -17% $25.93 14,687 22 Aug 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted-average price. The shares were sold at prices ranging from $25.685 to $26.09. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.